After a heart attack, humans lose millions of heart muscle cells that cannot regrow, often leading to heart failure where the ...

National Resilience acquired the Triangle office in 2021. Since then, funding for gene therapy solutions has fallen.

UC Davis Health has premiered a new documentary on a family’s urgent journey across the globe to get their toddler in a clinical trial for patients with Duchenne Muscular Dystrophy, or DMD.

A study published in Human Gene Therapy has involved the generation of a human monoclonal antibody (mAb) directed against ...

The three-year partnership is another example of Vertex’s interest in improving on Casgevy, its CRISPR medicine for sickle cell and beta thalassemia.

WuXi AppTec, the Shanghai-based biotech giant, has sold its South Philly-based WuXi Advanced Therapies contract manufacturing ...

We recently compiled a list of the 15 Small-Cap Stocks Poised to Outperform in 2025. In this article, we are going to take a ...

Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies ...

Gene-editing kicked off 2024 with a bang in the medical sector but closed the year with a whimper. It started with the FDA ...

The biotechnology market experiences significant growth, fueled by advancements in genetic therapies and supportive global ...

Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of ...

A new study published in the peer-reviewed journal Human Gene Therapy involved the generation of a human monoclonal antibody ...